http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1110551-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 |
| filingDate | 1995-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f31940a9a8b41a59a4ffb9522dff50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c01afac73cca356c25ec33b4aec20858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f3fc710a17f142da0d8b86d4d1f558 |
| publicationDate | 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1110551-B1 |
| titleOfInvention | Ocular tension lowering agent |
| abstract | Use, in the manufacture of a medicament suitable for local application to the eyes for use in combination with a beta -blocker for the treatment of ocular hypertension and/or glaucoma, of a compound of general formula (I): <CHEM> wherein: R<1> represents alkyl, alkenyl or a group of formula R<5>-A-B- (R<5> represents hydrogen, alkyl, cycloalkyl or aliphatic acyl, A represents oxygen or sulfur, and B represents a single bond or alkylene); R<2> represents alkyl, alkenyl or a group of formula -C(R<6>)(R<7>)(R<8>) (R<6> represents hydroxyl or alkoxy, and R<7> and R<8> represent hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl); R<3> represents carboxyl or a group of formula -CON(R<9>)(R<10>) (R<9> and R<10> represent hydrogen or alkyl optionally substituted by 1 to 3 substituents from Substituent group (I)); and optionally substituted by 1 to 3 substituents from Substituent group (I)); and R<4> represents carboxyl, carboxycarbonyl or tetrazol-5-yl; substituent group (I): aryl, 5- or 6-membered heteroaromatic ring group, halogen, hydroxyl, alkoxy, carboxyl, alkoxycarbonyl, amino, aliphatic acylamide and aromatic acylamide. |
| priorityDate | 1994-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1006.